Labiotech.eu

Podcast 23 Aug 2024

New German biotech spins out to develop radiotherapeutics

While it is currently owned by the Eckert & Ziegler Group, Pentixapharm will soon be spun off as a separate company. Listen to our conversation with Andreas Eckert, founder of the company

August 23, 2024

Best in Biotech 22 Aug 2024

Seven companies transforming the biotech industry in Italy

Delve into Italy’s biotech landscape with seven companies that are leading the charge in the European country.

August 22, 2024 - 9 minutesmins - By Jules Adam

In Depth 21 Aug 2024

The promise of antisense oligonucleotides in precision medicine

Find out all about antisense oligonucleotides, which have gained a lot of popularity in recent years and could treat numerous diseases.

August 21, 2024 - 11 minutesmins - By Willow Shah-Neville

News and Trends 20 Aug 2024

Fighting mpox: promising vaccines to watch

As Bavarian Nordic ramps up production of the only marketed mpox vaccine, a few clinical trials are underway to combat the outbreak.

August 20, 2024 - 6 minutesmins - By Roohi Mariam Peter

Podcast 16 Aug 2024

Challenging the European biotech funding status quo

Explore the latest trends in biotech investments and funding strategies in Europe with insights from 4BIO Capital’s Dima Kuzmin.

August 16, 2024

Best in Biotech 15 Aug 2024

10 neuroscience biotech companies you should know about

Learn more about nine of the top neuroscience biotech companies looking to develop treatments for difficult-to-treat neurological conditions.

August 15, 2024 - 12 minutesmins - By Willow Shah-Neville

News and Trends 14 Aug 2024

CAR-T drugs and parkinsonism: a cause for concern?

CAR-T therapies come with boxed warnings of serious neurotoxic side effects. Now, growing concerns over parkinsonism have led to a clinical trial halt.

August 14, 2024 - 3 minutesmins - By Roohi Mariam Peter

News and Trends 13 Aug 2024

Biologics vs. drugs: What does Ipsen’s lost case against the FDA mean for the industry?

Ipsen has lost a court case against U.S. regulators to have its blockbuster cancer medication Somatuline Depot regarded as a biologic instead of a drug.

August 13, 2024 - 4 minutesmins - By Roohi Mariam Peter

In Depth 9 Aug 2024

The therapeutic potential of circular RNA: Could it soon trump mRNA technology?

Find out about circular RNA, an emerging technology that could hold a lot of promise for next-generation vaccines and gene therapies.

August 9, 2024 - 5 minutesmins - By Willow Shah-Neville

Podcast 9 Aug 2024

Rebroadcast: Epigenetic editing – the power of CRISPR without cutting DNA

This week, we discuss epigenetic editing, why it’s reversible, treating FSHD and other conditions, with Epic Bio founder, Dr Stanley Qi.

August 9, 2024

In Depth 6 Aug 2024

The biggest private biotech investments in July 2024

The companies Cardurion Pharmaceuticals, Beacon Therapeutics, and Third Arc Bio bagged the biggest private biotech investments in July 2024.

August 6, 2024 - 3 minutesmins - By Willow Shah-Neville

Best in Biotech 2 Aug 2024

Six epigenetics companies making strides in 2024

In this article, we take a look at six epigenetics companies that are significant as well as up-and-coming players in the industry.

August 2, 2024 - 7 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

New German biotech spins out to develop radiotherapeutics

Seven companies transforming the biotech industry in Italy

The promise of antisense oligonucleotides in precision medicine

Fighting mpox: promising vaccines to watch

Challenging the European biotech funding status quo

10 neuroscience biotech companies you should know about

CAR-T drugs and parkinsonism: a cause for concern?

Biologics vs. drugs: What does Ipsen’s lost case against the FDA mean for the industry?

The therapeutic potential of circular RNA: Could it soon trump mRNA technology?

Rebroadcast: Epigenetic editing – the power of CRISPR without cutting DNA

The biggest private biotech investments in July 2024

Six epigenetics companies making strides in 2024

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!